Innovative Study Investigates Neural, Epigenetic, and Behavioral Contributions to Autism Spectrum Disorder

Recent research uncovers how neural, epigenetic, and behavioral factors interact to influence autism spectrum disorder, advancing diagnostic strategies through machine learning approaches.
Autism spectrum disorder (ASD) is a complex neurodevelopmental condition affecting approximately 1 in 127 individuals globally. It manifests through atypical brain development, leading to differences in communication, social interactions, behavioral patterns, and sensory processing. Recognizing the multifaceted nature of ASD, recent research emphasizes the interplay of genetic, epigenetic, neural, and environmental factors.
A recent study conducted by scientists at the Korea Brain Research Institute and the University of Fukui in Japan provided deeper insights into these contributing elements. The researchers focused on brain structure, neural connectivity, epigenetic modifications, and behavioral responses. Their findings, published in Translational Psychiatry, contribute to a better understanding of the disorder's intricate mechanisms and pave the way for more precise diagnostic tools.
The researchers highlighted the heterogeneity of ASD, noting its association with abnormal behavioral responses to sensory stimuli. Despite advances, there remains limited understanding of how the combined effects of brain and epigenetic factors, along with behavioral abnormalities, influence ASD.
To explore these dimensions, the team conducted an experiment involving 34 individuals diagnosed with ASD and 72 neurotypical controls. Participants completed the Adolescent-Adult Sensory Profile, a questionnaire assessing sensory responses. Subsequently, neuroimaging techniques measured brain volume and functional connectivity at rest, while saliva samples provided data on epigenetic markers, specifically DNA methylation levels of oxytocin and vasopressin receptor genes.
The collected data were analyzed using machine learning models to evaluate the contribution of neural, epigenetic, and behavioral factors to ASD. Notably, models integrating all three dimensions predicted ASD diagnosis more accurately than models based on individual factors. Key findings included thalamo-cortical hyperconnectivity and epigenetic modifications of the AVPR1A gene as significant contributors.
These insights suggest that combining neuroimaging, epigenetic biomarkers, and behavioral assessments could enhance diagnostic precision. The research team anticipates that such multidimensional approaches will facilitate the development of advanced machine learning tools to support early and accurate ASD diagnosis, ultimately improving intervention strategies.
This study underscores the importance of understanding the complex interactions among various factors contributing to ASD and offers promising avenues for future research and clinical application. Source: https://medicalxpress.com/news/2025-10-explores-contribution-neural-epigenetic-behavioral.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Molecular Stress in Aging Neurons Heightens Risk of Neurodegenerative Diseases
Recent research reveals that molecular stress in aging neurons increases their vulnerability to neurodegenerative diseases, paving the way for new therapeutic strategies.
Engineered Gut Bacteria Boost Survival Rates in Colorectal Cancer Treatment
Scientists have developed engineered gut bacteria that stimulate immune responses within tumors, offering a promising new therapy for colorectal cancer patients. This innovative approach enhances immune activation, suppresses tumor growth, and improves survival outcomes.
Elinzanetant Effectively Reduces Vasomotor Symptoms in Breast Cancer Patients on Endocrine Therapy
A new phase 3 trial shows that elinzanetant significantly reduces hot flashes and night sweats in women undergoing endocrine therapy for breast cancer, improving quality of life.
Breakthrough Identifies Unique Pathway for Chronic Pain, Paving Way for New Treatments
Scientists have identified a unique neural pathway responsible for chronic pain, opening new avenues for targeted treatments for conditions like fibromyalgia and rheumatoid arthritis.



